Damalakienės klinika, MB - financials and debts

Company age: 16 y. 1 mo.

Update

Damalakienės klinika - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 100,971 93,230 68,539 89,641 140,672 148,395 147,274 184,534
Profit before tax 8,378 7,247 4,150 8,831 8,294 14,396 6,505 8,389
Net profit 7,956 6,912 3,856 8,554 7,847 13,563 6,109 7,569
Equity 11,171 10,184 7,042 11,740 11,038 16,751 9,300 16,868
Liabilities 18,213 13,963 11,840 9,150 7,220 41,146 44,451 35,285
Non-current assets 17,789 13,595 9,897 12,277 9,551 43,642 39,116 34,550
Current assets 10,548 9,587 8,194 7,823 7,870 12,984 13,283 17,603
Total assets 28,337 23,182 18,091 20,100 17,421 56,626 52,399 52,153
Taxes paid
STI taxes - - - - - 17,624 17,317 13,929
Social insurance contributions - - - - - 13,089 16,605 10,444
Financial indicators
Revenue change y/y +22.9% -7.7% -26.5% +30.8% +56.9% +5.5% -0.8% +25.3%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 28.1% 29.8% 21.3% 42.6% 45.0% 24.0% 11.7% 14.5%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 71.2% 67.9% 54.8% 72.9% 71.1% 81.0% 65.7% 44.9%
Profit margin Net profit margin. Shows the overall profitability of the company. 7.9% 7.4% 5.6% 9.5% 5.6% 9.1% 4.1% 4.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 8.3% 7.8% 6.1% 9.9% 5.9% 9.7% 4.4% 4.5%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.6 1.4 1.7 0.8 0.7 2.5 4.8 2.1
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 21,257 19,978 15,817 22,410 35,168 32,377 36,819 48,140

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Damalakienės klinika - Social security debts

From To Debt, €
2025-07-16 2025-07-16 973.91
2024-10-29 2024-11-14 0.48
2024-10-24 2024-10-27 0.48
2024-07-24 2024-08-15 0.37
2024-04-23 2024-05-15 2.87
2024-01-23 2024-02-18 2.01
2023-11-20 2023-11-20 151.54
2023-11-16 2023-11-19 1387.29
2023-07-24 2023-07-24 1.18
2023-07-18 2023-07-23 0.72
2023-05-02 2023-05-11 0.78
2023-04-25 2023-04-28 0.78
2023-02-06 2023-02-12 0.90
2023-01-23 2023-02-03 0.90
2023-01-17 2023-01-17 1296.63
2022-12-29 2023-01-16 0.42
2022-08-10 2022-09-14 0.51
2021-11-16 2021-12-14 0.39
2021-11-09 2021-11-14 0.39
2021-09-16 2021-09-16 650.56

Damalakienės klinika - VMI tax arrears

As of 2026-09-02, the amount of overdue STI tax debt of the company Damalakienės klinika is: 1 €

From To Overdue, €
2026-09-01 2026-09-02 0.84
2026-08-31 2026-08-31 0.28
2026-08-14 2026-08-30 0.56
2026-08-12 2026-08-13 184.58
2026-08-02 2026-08-11 0.56
2026-07-26 2026-08-01 92.51
2026-04-10 2026-04-13 90.74
2026-04-09 2026-04-09 90.56
2026-03-02 2026-03-12 0.27
2026-02-21 2026-02-21 224.54
2026-02-18 2026-02-20 91.54
2025-12-15 2025-12-17 92.03
2025-11-21 2025-12-14 0.02
2025-11-18 2025-11-18 92.78
2025-11-06 2025-11-17 92.54
2025-10-17 2025-10-23 46.47
2025-10-02 2025-10-16 0.58
2025-09-30 2025-10-01 88.3
2025-09-28 2025-09-29 88.24
2025-09-16 2025-09-27 87.74
2025-02-25 2025-02-25 136.67
2025-02-23 2025-02-24 136.55
2025-02-20 2025-02-22 136.39
2025-02-14 2025-02-17 91.87
2025-01-15 2025-01-15 278.56
2024-12-20 2025-01-14 0.3
2024-12-14 2024-12-16 92.18
2024-10-16 2024-10-16 0.13
2024-10-02 2024-10-15 4.6

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Damalakienes klinika, MB (code 302533936) is a small partnership engaged in dental practice care activities. In 2025, the company generated EUR 184.5K in revenue, up 25.3% year on year and 24.4% over two years. Net profit increased to EUR 7.6K from EUR 6.1K in 2024, after EUR 13.6K in 2023, indicating a weaker 2024 followed by a partial recovery in 2025. The profit margin remained at 4.1% in both 2024 and 2025, compared with 9.1% in 2023. At the end of 2025, total assets were EUR 52.2K, with equity of EUR 16.9K and liabilities of EUR 35.3K. Long-term assets amounted to EUR 34.5K and short-term assets to EUR 17.6K. Key ratios show debt-to-equity at 2.09, an equity ratio of 32.3%, ROE of 44.9%, ROA of 14.5%, and asset turnover of 3.54x. Revenue per employee was EUR 61.5K and profit per employee EUR 2.5K.